Abide Therapeutics in the News

View All Events

American Academy of Neurology

Ewgeni Jakubovski, from the Hannover Medical School and Chan Beals, Chief Medical Officer at Abide Therapeutics, will make the following presentation at the Emerging Science Data Blitz and Poster Session:

"ABX-1431, A First-in-Class Endocannabinoid Modulator, Improves Tics and the Urge to Tic in Adult Patients with Tourette Syndrome"

Date & Time: April 24th, 2018; 5:48 p.m. PT

Location: Los Angeles, CA

Media Contact

Patty Pilon
Abide Therapeutics
Tel: +1 619.244.2679